EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis and Biological Activities Evaluation of Novel Pterostilbene‐Urea Derivatives as Potential Anti‐Inflammatory Agents

Shouchuan Wang, Shaoling Huang, Feng Peng, Yanchun Wu, Weigao Pan, Yunhou Huang iD, Peng Luo

Chemistry & Biodiversity · 2025-02 · 22 (2)

DOI: 10.1002/cbdv.202402016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 09.11.2024. Verfasst von Shouchuan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Zhuang Medical College, Guangxi University of Chinese Medicine, Nanning, 530001, China. Hauptthemen laut MEDLINE: Drug Design, Stilbenes, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Guangxi University of Chinese Medicine, Guangxi Traditional Chinese Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

1. The toxicity of derivatives was removed by the reasonable modification of bioactive skeleton. 2. As potential COX‐2 inhibitor with IC 50 values ranging from 39.42 to 179.84 nM/L, compounds ( Q4‐Q10 , Q20 ) exhibited superior anti‐inflammatory activity at low micromolar concentrations. 3. Q7 (IC 50 (COX‐2) = 61.05 nM/L), Q10 (IC 50 (COX‐2) = 54.68 nM/L) and Q20 (IC 50 (COX‐2) = 39.42 nM/L) showed stronger COX‐2 inhibitory abilities than Celecoxib (IC 50 (COX‐2) = 67.89 nM/L). 4. The strongest anti‐inflammatory agent, Q20 (IC 50 NO = 9.96 μM/L, IC 50 (COX‐2) = 39.42 nM/L) effectively inhibited the secretion of IL‐1β and TNF‐α, exhibited the IC 50 values of 12.30 and 9.07 μM/L respectively. 5. Q20 exerted as anti‐inflammatory actives via targeting COX‐2, down‐regulating iNOS and TLR4 protein, and inhibiting the activation of NLRP3 inflammasome and NF‐κB signal pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DesignStilbenesCyclooxygenase 2Cyclooxygenase 2 InhibitorsAnimalsStructure-Activity RelationshipMiceRAW 264.7 CellsMolecular StructureAnti-Inflammatory AgentsHumansAnti-Inflammatory Agents, Non-SteroidalDose-Response Relationship, DrugInterleukin-1betaTumor Necrosis Factor-alphaLipopolysaccharidesNitric Oxide Synthase Type IINF-kappa BNLR Family, Pyrin Domain-Containing 3 Protein

Stichwörter der Autor:innen

COX-2 inhibitionMolecular dockingNF-κB signal pathwayNRLP3 inflammasomePterostilbene-urea derivatives

Substanzen

StilbenesCyclooxygenase 2Cyclooxygenase 2 InhibitorspterostilbeneAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalInterleukin-1betaTumor Necrosis Factor-alphaLipopolysaccharidesNitric Oxide Synthase Type II

Autor:innen und Institutionen

  • Zhuang Medical College, Guangxi University of Chinese Medicine, Nanning, 530001, China.

ORCID-Profile: Yunhou Huang

Förderung

  • Guangxi University of Chinese Medicine
  • Guangxi Traditional Chinese Medical University

Zitieren

APA

Wang, S., Huang, S., Peng, F., Wu, Y., Pan, W., Huang, Y., & Luo, P. (2025). Design, Synthesis and Biological Activities Evaluation of Novel Pterostilbene‐Urea Derivatives as Potential Anti‐Inflammatory Agents. Chemistry & Biodiversity, 22(2). https://doi.org/10.1002/cbdv.202402016

Vancouver

Wang S, Huang S, Peng F, Wu Y, Pan W, Huang Y, et al. Design, Synthesis and Biological Activities Evaluation of Novel Pterostilbene‐Urea Derivatives as Potential Anti‐Inflammatory Agents. Chemistry & Biodiversity. 2025;22(2). doi:10.1002/cbdv.202402016

BibTeX
@article{Wang2025,
  author = {Wang, Shouchuan and Huang, Shaoling and Peng, Feng and Wu, Yanchun and Pan, Weigao and Huang, Yunhou and Luo, Peng},
  title = {Design, Synthesis and Biological Activities Evaluation of Novel Pterostilbene‐Urea Derivatives as Potential Anti‐Inflammatory Agents},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  volume = {22},
  number = {2},
  doi = {10.1002/cbdv.202402016}
}
Kostenlos starten →